Kiniksa Pharmaceuticals International plc Class A (KNSA) Next Earnings Date & Options-Implied ±7.3% Move
Kiniksa Pharmaceuticals International plc Class A (KNSA) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (64/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+0.0% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Options-Implied Post-Earnings ±7.3% Bell Curve
Will KNSA Beat & Rip or Miss Next Quarter?
Trailing EPS: $0.75 • YoY Revenue Growth: 60.1%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $677.6M | $59.0M | $136.4M | 88.5% |
| FY 2024 | 2024-12-31 | $423.2M | -$43.2M | $25.4M | 85.6% |
| FY 2023 | 2023-12-31 | $270.3M | $14.1M | $1.1M | 44% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring KNSA)
- ✓Live walkthrough of KNSA's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
KNSA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +60.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on KNSA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for KNSA. Explore sector supply chains on /butterfly.
KNSA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is KNSA's next earnings date?
Based on SEC filing cadence, Kiniksa Pharmaceuticals International plc Class A (KNSA)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is KNSA stock expected to move on earnings?
Options markets currently imply a ±7.3% post-earnings move for KNSA, projecting a trading range between $90.44 and $104.68.